ITK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A5YKK6 | Y1572 | Sugiyama | CNOT1 CDC39 KIAA1007 NOT1 AD-005 | RMPEQIRLKVGGVDPKQLAVyEEFARNVPGFLPTNDLSQPT |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00233 | Y70 | Sugiyama | PSMD9 | IGMNEPLVDCEGyPRSDVDLyQVRTARHNIICLQNDHKAVM |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15234 | Y240 | Sugiyama | CASC3 MLN51 | HDKFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRK |
| O15234 | Y242 | Sugiyama | CASC3 MLN51 | KFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRKPR |
| O15357 | Y190 | Sugiyama | INPPL1 SHIP2 | AAESAPNGLSTVSHDYLKGsyGLDLEAVRGGASHLPHLTRT |
| O15371 | Y30 | Sugiyama | EIF3D EIF3S7 | QDNPSGWGPCAVPEQFRDMPyQPFsKGDRLGKVADWtGAty |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O43143 | Y128 | Sugiyama | DHX15 DBP1 DDX15 | HTSLPQCINPFTNLPHTPRyyDILKKRLQLPVWEYKDRFTD |
| O43252 | Y238 | Sugiyama | PAPSS1 ATPSK1 PAPSS | ELLQERDIVPVDAsYEVKELyVPENKLHLAKTDAETLPALK |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y296 | Sugiyama | HNRNPR HNRPR | VILYHQPDDKKKNRGFCFLEyEDHKSAAQARRRLMSGKVKV |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43765 | Y195 | Sugiyama | SGTA SGT SGT1 | HVEAVAYYKKALELDPDNEtyKsNLKIAELKLREAPSPTGG |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y291 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDVMFGG |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y293 | Sugiyama | SYNCRIP HNRPQ NSAP1 | VILyHQPDDKKKNRGFCFLEyEDHKTAAQARRRLMSGKVKV |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | Y134 | Sugiyama | EIF5B IF2 KIAA0741 | EELEDKDsKSKKTAKPKVEMysGsDDDDDFNKLPKKAKGKA |
| O75223 | Y156 | Sugiyama | GGCT C7orf24 CRF21 | sPQYKKIICMGAKENGLPLEyQEKLKAIEPNDytGKVsEEI |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75534 | S598 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | KVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQGM |
| O75534 | Y597 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | EKVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQG |
| O75718 | Y372 | Sugiyama | CRTAP CASP | FQPRPEAVQFFNVTTLQKELyDFAKENIMDDDEGEVVEyVD |
| O75791 | Y45 | PSP | GRAP2 GADS GRB2L GRID | LKILSNQEEWFKAELGsQEGyVPKNFIDIQFPKWFHEGLSR |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y124 | Sugiyama | ZRANB2 ZIS ZNF265 | GGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVGPAsI |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04632 | Y87 | Sugiyama | CAPNS1 CAPN4 CAPNS | sAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLFAQ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P06493 | Y15 | Sugiyama | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | ______MEDyTKIEKIGEGtyGVVyKGRHKTTGQVVAMKKI |
| P06730 | Y197 | Sugiyama | EIF4E EIF4EL1 EIF4F | THIGRVYKERLGLPPKIVIGyQsHADTAtKsGsttKNRFVV |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y257 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | TDKVVIGMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLA |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06899 | Y38 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P07195 | Y240 | Sugiyama | LDHB | GTDNDSENWKEVHKMVVEsAyEVIKLKGYTNWAIGLSVADL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | T101 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAGRE |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07711 | Y112 | Sugiyama | CTSL CTSL1 | MNGFQNRKPRKGKVFQEPLFyEAPRSVDWREKGyVTPVKNQ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07858 | Y244 | Sugiyama | CTSB CPSB | HYGYNSYSVSNSEKDIMAEIyKNGPVEGAFSVYSDFLLYKS |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y438 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KKCLELFtELAEDKENyKKFyEQFSKNIKLGIHEDsQNRKK |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09211 | Y50 | Sugiyama | GSTP1 FAEES3 GST3 | KEEVVTVETWQEGsLKASCLyGQLPKFQDGDLtLyQsNtIL |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09496 | Y147 | Sugiyama | CLTA | NSRKQEAEWKEKAIKELEEWyARQDEQLQKTKANNRVADEA |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09972 | Y358 | Sugiyama | ALDOC ALDC | AAQGKYEGSGEDGGAAAQsLyIANHAY______________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0DPH7 | Y224 | Sugiyama | TUBA3C TUBA2 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10412 | Y71 | Sugiyama | H1-4 H1F4 HIST1H1E | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P10747 | Y191 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CD28 | TVAFIIFWVRSKRSRLLHsDyMNMtPRRPGPTRKHyQPyAP |
| P10747 | Y206 | SIGNOR|iPTMNet|EPSD | CD28 | LLHsDyMNMtPRRPGPTRKHyQPyAPPRDFAAyRS______ |
| P10747 | Y209 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CD28 | sDyMNMtPRRPGPTRKHyQPyAPPRDFAAyRS_________ |
| P10747 | Y218 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | CD28 | RPGPTRKHyQPyAPPRDFAAyRS__________________ |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | Y134 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FYPEEVSSMVLTKMKEIAEAyLGKtVTNAVVtVPAyFNDsQ |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13639 | Y373 | Sugiyama | EEF2 EF2 | MITIHLPSPVTAQKyRCELLyEGPPDDEAAMGIKsCDPKGP |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | Y87 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | FEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTSL |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14314 | Y465 | Sugiyama | PRKCSH G19P1 | sLGtWGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLC |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15880 | S264 | Sugiyama | RPS2 RPS4 | ISKTysyLtPDLWKEtVFtKsPyQEFtDHLVKtHtRVsVQR |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P15880 | Y266 | Sugiyama | RPS2 RPS4 | KTysyLtPDLWKEtVFtKsPyQEFtDHLVKtHtRVsVQRtQ |
| P16402 | Y72 | Sugiyama | H1-3 H1F3 HIST1H1D | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16403 | Y71 | Sugiyama | H1-2 H1F2 HIST1H1C | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17931 | Y221 | Sugiyama | LGALS3 MAC2 | QVLVEPDHFKVAVNDAHLLQyNHRVKKLNEISKLGISGDID |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18124 | Y82 | Sugiyama | RPL7 | RQMYRTEIRMARMARKAGNFyVPAEPKLAFVIRIRGINGVS |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18615 | Y367 | Sugiyama | NELFE RD RDBP | SLAVQNsPKGCHRDKRTQIVysDDVyKENLVDGF_______ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y133 | Sugiyama | PGAM1 PGAMA CDABP0006 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsC |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y26 | Sugiyama | PGAM1 PGAMA CDABP0006 | LVLIRHGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19174 | Y783 | GPS6|EPSD|PSP | PLCG1 PLC1 | KIGTAEPDyGALyEGRNPGFyVEANPMPTFKCAVKALFDYK |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P21127 | Y449 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | LQGCRsVEEFQCLNRIEEGtyGVVYRAKDKKTDEIVALKRL |
| P21980 | T368 | Sugiyama | TGM2 | QPGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKy |
| P22087 | Y118 | Sugiyama | FBL FIB1 FLRN | ICRGKEDALVTKNLVPGEsVyGEKRVsIsEGDDKIEyRAWN |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y451 | Sugiyama | UBA1 A1S9T UBE1 | CLPEDKEVLTEDKCLQRQNRyDGQVAVFGsDLQEKLGKQKY |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22492 | Y75 | Sugiyama | H1-6 H1FT H1T HIST1H1T | SQERVGMSLVALKKALAAAGyDVEKNNSRIKLSLKSLVNKG |
| P22626 | S341 | Sugiyama | HNRNPA2B1 HNRPA2B1 | FGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy________ |
| P22626 | S344 | Sugiyama | HNRNPA2B1 HNRPA2B1 | sRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___________ |
| P22626 | Y347 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MGGPyGGGNyGPGGsGGsGGyGGRsRy______________ |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | S491 | Sugiyama | SFPQ PSF | QKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEKN |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23284 | Y119 | Sugiyama | PPIB CYPB | DFMIQGGDFtRGDGtGGKsIyGERFPDENFKLKHyGPGWVs |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | Y34 | Sugiyama | RPS3 OK/SW-cl.26 | DGIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATR |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23527 | Y38 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | T88 | Sugiyama | CFL1 CFL | yAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P24941 | Y15 | Sugiyama | CDK2 CDKN2 | ______MENFQKVEKIGEGtyGVVyKARNKLTGEVVALKKI |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y45 | Sugiyama | MCM3 | DEEDQGIyQsKVRELIsDNQyRLIVNVNDLRRKNEKRANRL |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P25787 | Y57 | Sugiyama | PSMA2 HC3 PSC3 | GIKAANGVVLATEKKQKSILyDERSVHKVEPITKHIGLVys |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26640 | Y601 | Sugiyama | VARS1 G7A VARS VARS2 | VDMDFGTGAVKITPAHDQNDyEVGQRHGLEAIsIMDsRGAL |
| P26885 | Y112 | Sugiyama | FKBP2 FKBP13 | GLLGMCEGEKRKLVIPsELGyGERGAPPKIPGGATLVFEVE |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y144 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | DKEGysGVGLLsRQCPLKVsyGIGDEEHDQEGRVIVAEFDS |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P28074 | Y236 | Sugiyama | PSMB5 LMPX MB1 X | RRAIyQATYRDAysGGAVNLyHVREDGWIRVSsDNVADLHE |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | S308 | Sugiyama | TKT | PPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQALAKL |
| P29401 | Y202 | Sugiyama | TKT | LDINRLGQsDPAPLQHQMDIyQKRCEAFGWHAIIVDGHSVE |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y181 | Sugiyama | PEBP1 PBP PEBP | RAPVAGtCyQAEWDDyVPKLyEQLsGK______________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | Y693 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | TMKAKRPELRNYFRSQIDDLyStIKV_______________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33778 | Y38 | Sugiyama | H2BC3 H2BFF HIST1H2BB | AITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSK |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33993 | Y102 | Sugiyama | MCM7 CDC47 MCM2 | QELLPQYKEREVVNKDVLDVyIEHRLMMEQRSRDPGMVRsP |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y336 | Sugiyama | HSPA4 APG2 HSPH2 | RVEPPLRSVLEQTKLKKEDIyAVEIVGGATRIPAVKEKISK |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35637 | Y325 | Sugiyama | FUS TLS | FKQIGIIKTNKKTGQPMINLyTDRETGKLKGEAtVsFDDPP |
| P35637 | Y468 | Sugiyama | FUS TLS | KAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRGGYRGRG |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P38646 | Y652 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | NIRQAAssLQQASLKLFEMAyKKMAsEREGSGsSGTGEQKE |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P40939 | Y637 | Sugiyama | HADHA HADH | ELLTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILA |
| P40939 | Y639 | Sugiyama | HADHA HADH | LTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILASL |
| P41227 | Y145 | Sugiyama | NAA10 ARD1 ARD1A TE2 | TLNFQISEVEPKyyADGEDAyAMKRDLtQMADELRRHLELK |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42680 | Y206 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | TEC PSCTK4 | AMyDFQAAEGHDLRLERGQEyLILEKNDVHWWRARDKYGNE |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y240 | Sugiyama | RPL5 MSTP030 | KKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPVyEKKPKKE |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46940 | Y1095 | Sugiyama | IQGAP1 KIAA0051 | VVKEIMDDKSLNIKTDPVDIyKsWVNQMESQTGEASKLPyD |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P47756 | Y232 | Sugiyama | CAPZB | NIGRLVEDMENKIRstLNEIyFGKTKDIVNGLRSVQTFADK |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | Y277 | Sugiyama | FASN FAS | KEQGVtFPsGDIQEQLIRSLyQsAGVAPEsFEyIEAHGtGT |
| P49327 | Y289 | Sugiyama | FASN FAS | QEQLIRSLyQsAGVAPEsFEyIEAHGtGTKVGDPQELNGIt |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49419 | T67 | Sugiyama | ALDH7A1 ATQ1 | LREENEGVyNGSWGGRGEVIttyCPANNEPIARVRQAsVAD |
| P50454 | Y246 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | VTRSYTVGVMMMHRTGLyNyyDDEKEKLQIVEMPLAHKLsS |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51813 | Y216 | SIGNOR|iPTMNet|EPSD|PSP | BMX | NESKKNyGSQPPsSSTSLAQyDSNSKKIyGSQPNFNMQYIP |
| P51813 | Y224 | SIGNOR|iPTMNet|EPSD | BMX | SQPPsSSTSLAQyDSNSKKIyGSQPNFNMQYIPREDFPDWW |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P53396 | Y659 | Sugiyama | ACLY | TGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISRTTD |
| P53621 | S730 | Sugiyama | COPA | TGNLEKLRKMMKIAEIRKDMsGHyQNALyLGDVSERVRILK |
| P53621 | Y738 | Sugiyama | COPA | KMMKIAEIRKDMsGHyQNALyLGDVSERVRILKNCGQKsLA |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55884 | Y768 | Sugiyama | EIF3B EIF3S9 | ERRRTMMEDFRKYRKMAQELyMEQKNERLELRGGVDTDELD |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60228 | Y445 | Sugiyama | EIF3E EIF3S6 INT6 | KLNQNSRSEAPNWAtQDsGFy____________________ |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61313 | Y62 | Sugiyama | RPL15 EC45 TCBAP0781 | PTRPDKARRLGYKAKQGyVIyRIRVRRGGRKRPVPKGAtyG |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P61353 | Y38 | Sugiyama | RPL27 | YSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMG |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | T70 | Sugiyama | HNRNPK HNRPK | QSKNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsI |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62191 | Y439 | Sugiyama | PSMC1 | FKKSKENVLyKKQEGtPEGLyL___________________ |
| P62195 | S120 | Sugiyama | PSMC5 SUG1 | DKNIDINDVtPNCRVALRNDsytLHKILPNKVDPLVSLMMV |
| P62195 | Y121 | Sugiyama | PSMC5 SUG1 | KNIDINDVtPNCRVALRNDsytLHKILPNKVDPLVSLMMVE |
| P62241 | S115 | Sugiyama | RPS8 OK/SW-cl.83 | TLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEE |
| P62241 | Y113 | Sugiyama | RPS8 OK/SW-cl.83 | TKTLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEE |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62249 | Y115 | Sugiyama | RPS16 | YYQKYVDEASKKEIKDILIQyDRtLLVADPRRCESKKFGGP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y117 | Sugiyama | RPL23A | VFIVDVKANKHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAY |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62753 | Y28 | Sugiyama | RPS6 OK/SW-cl.2 | PAtGCQKLIEVDDERKLRtFyEKRMAtEVAADALGEEWKGY |
| P62805 | Y52 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | KPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIRDAVt |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62847 | Y76 | Sugiyama | RPS24 | FVFGFRTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGL |
| P62847 | Y81 | Sugiyama | RPS24 | RTHFGGGKttGFGMIyDsLDyAKKNEPKHRLARHGLYEKKK |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y254 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y224 | Sugiyama | TUBA1B | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68366 | Y224 | Sugiyama | TUBA4A TUBA1 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P84098 | Y120 | Sugiyama | RPL19 | RILRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILME |
| P84098 | Y124 | Sugiyama | RPL19 | RLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHIHK |
| P84103 | Y13 | Sugiyama | SRSF3 SFRS3 SRP20 | ________MHRDsCPLDCKVyVGNLGNNGNKtELERAFGyy |
| P84103 | Y33 | Sugiyama | SRSF3 SFRS3 SRP20 | yVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVEF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98179 | Y118 | Sugiyama | RBM3 RNPL | GRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNGR |
| Q00059 | Y165 | Sugiyama | TFAM TCF6 TCF6L2 | KKKELTLLGKPKRPRsAYNVyVAERFQEAKGDsPQEKLKTV |
| Q00526 | Y15 | Sugiyama | CDK3 CDKN3 | ______MDMFQKVEKIGEGtyGVVyKAKNRETGQLVALKKI |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00610 | Y899 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LAKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACV |
| Q00610 | Y900 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AKIyIDsNNNPERFLRENPyyDsRVVGKYCEKRDPHLACVA |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q01518 | Y164 | Sugiyama | CAP1 CAP | VAMAPKPGPYVKEMNDAAMFytNRVLKEYKDVDKKHVDWVK |
| Q02539 | Y74 | Sugiyama | H1-1 H1F1 HIST1H1A | SKERGGVSLAALKKALAAAGyDVEKNNSRIKLGIKsLVsKG |
| Q02543 | Y63 | Sugiyama | RPL18A | RFWYFVSQLKKMKKssGEIVyCGQVFEKsPLRVKNFGIWLR |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q05639 | Y254 | Sugiyama | EEF1A2 EEF1AL STN | TILPPTRPTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRP |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06187 | Y223 | SIGNOR|iPTMNet|EPSD|PSP | BTK AGMX1 ATK BPK | PPEPAAAPVSTSELKKVVALyDyMPMNANDLQLRKGDEYFI |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | Y669 | Sugiyama | TJP1 ZO1 | IFGPIADVAREKLAREEPDIyQIAKSEPRDAGTDQRSsGII |
| Q07955 | Y189 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | TYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRsRs |
| Q07955 | Y37 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | RIyVGNLPPDIRtKDIEDVFyKYGAIRDIDLKNRRGGPPFA |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08881 | S204 | Sugiyama | ITK EMT LYK | TNDPQELALRRNEEyCLLDSsEIHWWRVQDRNGHEGyVPss |
| Q08881 | S223 | Sugiyama | ITK EMT LYK | SsEIHWWRVQDRNGHEGyVPssyLVEKSPNNLEtyEWyNKS |
| Q08881 | S224 | Sugiyama | ITK EMT LYK | sEIHWWRVQDRNGHEGyVPssyLVEKSPNNLEtyEWyNKSI |
| Q08881 | S284 | Sugiyama | ITK EMT LYK | VRDSRTAGTytVSVFTKAVVsENNPCIKHYHIKETNDNPKR |
| Q08881 | S514 | Sugiyama | ITK EMT LYK | QVIKVSDFGMTRFVLDDQytssTGtKFPVKWAsPEVFSFsR |
| Q08881 | S526 | Sugiyama | ITK EMT LYK | FVLDDQytssTGtKFPVKWAsPEVFSFsRYSSKSDVWSFGV |
| Q08881 | S533 | Sugiyama | ITK EMT LYK | tssTGtKFPVKWAsPEVFSFsRYSSKSDVWSFGVLMWEVFS |
| Q08881 | S563 | Sugiyama | ITK EMT LYK | SFGVLMWEVFSEGKIPYENRsNsEVVEDIsTGFRLYKPRLA |
| Q08881 | S565 | iPTMNet|EPSD|Sugiyama | ITK EMT LYK | GVLMWEVFSEGKIPYENRsNsEVVEDIsTGFRLYKPRLAST |
| Q08881 | S572 | Sugiyama | ITK EMT LYK | FSEGKIPYENRsNsEVVEDIsTGFRLYKPRLASTHVyQIMN |
| Q08881 | S71 | Sugiyama | ITK EMT LYK | LKGSIELSRIKCVEIVKSDIsIPCHyKYPFQVVHDNyLLyV |
| Q08881 | T274 | Sugiyama | ITK EMT LYK | LDTGKEGAFMVRDSRTAGTytVSVFTKAVVsENNPCIKHYH |
| Q08881 | T513 | Sugiyama | ITK EMT LYK | NQVIKVSDFGMTRFVLDDQytssTGtKFPVKWAsPEVFSFs |
| Q08881 | Y120 | Sugiyama | ITK EMT LYK | QRWVLALKEETRNNNSLVPKyHPNFWMDGKWRCCSQLEKLA |
| Q08881 | Y146 | Sugiyama | ITK EMT LYK | MDGKWRCCSQLEKLATGCAQyDPTKNASKKPLPPTPEDNRR |
| Q08881 | Y180 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | ITK EMT LYK | TPEDNRRPLWEPEETVVIALyDYQTNDPQELALRRNEEyCL |
| Q08881 | Y198 | Sugiyama | ITK EMT LYK | ALyDYQTNDPQELALRRNEEyCLLDSsEIHWWRVQDRNGHE |
| Q08881 | Y220 | Sugiyama | ITK EMT LYK | LLDSsEIHWWRVQDRNGHEGyVPssyLVEKSPNNLEtyEWy |
| Q08881 | Y225 | Sugiyama | ITK EMT LYK | EIHWWRVQDRNGHEGyVPssyLVEKSPNNLEtyEWyNKSIS |
| Q08881 | Y237 | Sugiyama | ITK EMT LYK | HEGyVPssyLVEKSPNNLEtyEWyNKSISRDKAEKLLLDTG |
| Q08881 | Y240 | Sugiyama | ITK EMT LYK | yVPssyLVEKSPNNLEtyEWyNKSISRDKAEKLLLDTGKEG |
| Q08881 | Y273 | Sugiyama | ITK EMT LYK | LLDTGKEGAFMVRDSRTAGTytVSVFTKAVVsENNPCIKHY |
| Q08881 | Y336 | Sugiyama | ITK EMT LYK | IPLLINYHQHNGGGLVTRLRyPVCFGRQKAPVTAGLRYGKW |
| Q08881 | Y40 | Sugiyama | ITK EMT LYK | RTSPSNFKVRFFVLTKASLAyFEDRHGKKRTLKGSIELSRI |
| Q08881 | Y512 | Sugiyama | ITK EMT LYK | ENQVIKVSDFGMTRFVLDDQytssTGtKFPVKWAsPEVFSF |
| Q08881 | Y76 | Sugiyama | ITK EMT LYK | ELSRIKCVEIVKSDIsIPCHyKYPFQVVHDNyLLyVFAPDR |
| Q08881 | Y87 | Sugiyama | ITK EMT LYK | KSDIsIPCHyKYPFQVVHDNyLLyVFAPDRESRQRWVLALK |
| Q08881 | Y90 | Sugiyama | ITK EMT LYK | IsIPCHyKYPFQVVHDNyLLyVFAPDRESRQRWVLALKEET |
| Q12965 | Y971 | Sugiyama | MYO1E MYO1C | PVRAAPPPPGyHQNGVIRNQyVPYPHAPGsQRSNQKSLyTs |
| Q12996 | Y708 | Sugiyama | CSTF3 | NEDsDEDEEKGAVVPPVHDIyRARQQKRIR___________ |
| Q13094 | Y173 | EPSD|PSP | LCP2 | EEALQNSILPAKPFPNSNSMyIDRPPSGKTPQQPPVPPQRP |
| Q13242 | Y152 | Sugiyama | SRSF9 SFRS9 SRP30C | REAGDVCYADVQKDGVGMVEyLRKEDMEYALRKLDDTKFRs |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13283 | Y125 | Sugiyama | G3BP1 G3BP | LRRFMQtFVLAPEGsVANKFyVHNDIFRyQDEVFGGFVtEP |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13546 | Y387 | Sugiyama | RIPK1 RIP RIP1 | QEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVAYNR |
| Q13561 | S211 | Sugiyama | DCTN2 DCTN50 | SGGKttGtPPDssLVtyELHsRPEQDKFSQAAKVAELEKRL |
| Q13561 | Y207 | Sugiyama | DCTN2 DCTN50 | SKGGSGGKttGtPPDssLVtyELHsRPEQDKFSQAAKVAEL |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13573 | Y179 | Sugiyama | SNW1 SKIIP SKIP | VAAAMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRVIRM |
| Q13601 | Y287 | Sugiyama | KRR1 HRB2 | tPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKAKQA |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14004 | Y399 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | GGDVsPsPyssSsWRRsRsPysPVLRRSGKSRSRSPYSSRH |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14258 | Y245 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | NRQQDVRMTANRKVEQLQQEytEMKALLDASETTSTRKIKE |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q14980 | Y1836 | Sugiyama | NUMA1 NMP22 NUMA | NITMTKKLDVEEPDsANssFystRsAPAsQAsLRAtsstQs |
| Q14CX7 | Y19 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | __MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLK |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15417 | Y261 | Sugiyama | CNN3 | STISLQMGTNKVAsQKGMsVyGLGRQVYDPKYCAAPTEPVI |
| Q15424 | Y723 | Sugiyama | SAFB HAP HET SAFB1 | EQERRPAVRRPYDLDRRDDAyWPEAKRAALDERYHSDFNRQ |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15631 | Y210 | Sugiyama | TSN | sLRKRYDGLKYDVKKVEEVVyDLSIRGFNKETAAACVEK__ |
| Q15785 | Y25 | Sugiyama | TOMM34 URCC3 | FPDsVEELRAAGNESFRNGQyAEASALyGRALRVLQAQGss |
| Q15785 | Y54 | Sugiyama | TOMM34 URCC3 | RALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDC |
| Q16181 | Y306 | Sugiyama | SEPTIN7 CDC10 SEPT7 | RNMLIRTHMQDLKDVTNNVHyENyRSRKLAAVtyNGVDNNK |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16778 | Y38 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssK |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5JTH9 | Y1253 | Sugiyama | RRP12 KIAA0690 | YKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQGQF |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5VTE0 | Y254 | Sugiyama | EEF1A1P5 EEF1AL3 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6DN03 | Y38 | Sugiyama | H2BC20P HIST2H2BC | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y38 | Sugiyama | H2BC19P HIST2H2BD | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6PEY2 | Y224 | Sugiyama | TUBA3E | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UB99 | Y817 | Sugiyama | ANKRD11 ANCO1 | EDKEKLKKEKVYREDsAFDEyCNKNQFLENEDtKFsLsDDQ |
| Q6UN15 | Y454 | Sugiyama | FIP1L1 FIP1 RHE | LPGSAPsWPSLVDTSKQWDyyARREKDRDRERDRDRERDRD |
| Q71RC2 | Y425 | Sugiyama | LARP4 PP13296 | SRNFPAERHNPTVTGHQEQtyLQKETSTLQVEQNGDYGRGR |
| Q71U36 | Y224 | Sugiyama | TUBA1A TUBA3 | VDNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRF |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q7RTV0 | Y100 | Sugiyama | PHF5A | KDRDGCPKIVNLGSsKTDLFyERKKYGFKKR__________ |
| Q86UK7 | Y306 | Sugiyama | ZNF598 | QFSYAPRHSRRNEGVVGGEDyEEVDRysRQGRVARAGTRGA |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q86XP3 | Y573 | Sugiyama | DDX42 | VATDVAARGLDIPSIKTVINyDVARDIDTHTHRIGRTGRAG |
| Q8IXH6 | Y211 | Sugiyama | TP53INP2 C20orf110 DOR PINH | RQNRARESRPRRSKNQSsFIyQPCQRQFNY___________ |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y133 | Sugiyama | PGAM4 PGAM3 | KIWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSY |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8N257 | Y38 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | AVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssK |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8TDD1 | Y681 | Sugiyama | DDX54 | GPNRGAKRRREEARQRDQEFyIPyRPKDFDSERGLsIsGEG |
| Q8TDQ0 | Y265 | GPS6|SIGNOR|EPSD|PSP | HAVCR2 TIM3 TIMD3 | LPPSGLANAVAEGIRSEENIyTIEENVyEVEEPNEYYCYVS |
| Q8TEW0 | S386 | Sugiyama | PARD3 PAR3 PAR3A | YEQLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAP |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WXX5 | Y66 | Sugiyama | DNAJC9 | RVGEGDKEDATRRFQILGKVySVLSDREQRAVYDEQGTVDE |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q92522 | Y48 | Sugiyama | H1-10 H1FX | AALsPsKKRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLA |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96DT5 | T3057 | Sugiyama | DNAH11 | HKDSISLFMAHVHTTVNEMStRYYQNERRHNYTTPKSFLEQ |
| Q96EU6 | Y138 | Sugiyama | RRP36 C6orf153 HSPC253 | RDPRFDDLSGEYNPEVFDKtyQFLNDIRAKEKELVKKQLKK |
| Q96F63 | Y135 | Sugiyama | CCDC97 | LREEHLACFGHVRGDHRADFyCAEVARQGTARPRTLRTRLR |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96HN2 | Y372 | Sugiyama | AHCYL2 KIAA0828 | LCVPAMNVNDSVTKQKFDNLyCCRESILDGLKRTTDMMFGG |
| Q96LC7 | Y597 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SIGLEC10 SLG2 UNQ477/PRO940 | RRTQTETPRPRFSRHstILDyINVVPTAGPLAQKRNQKATP |
| Q96LC7 | Y667 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SIGLEC10 SLG2 UNQ477/PRO940 | PEPKSSTQAPESQESQEELHyATLNFPGVRPRPEARMPKGT |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96QK1 | Y791 | Sugiyama | VPS35 MEM3 TCCCTA00141 | HNtLEHLRLRREsPEsEGPIyEGLIL_______________ |
| Q96T37 | Y608 | Sugiyama | RBM15 OTT OTT1 | PPPPPVRERSTRTAATsVPAyEPLDSLDRRRDGWsLDRDRG |
| Q99426 | Y107 | Sugiyama | TBCB CG22 CKAP1 | VIDHsGARLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKR |
| Q99426 | Y114 | Sugiyama | TBCB CG22 CKAP1 | RLGEyEDVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyN |
| Q99460 | Y494 | Sugiyama | PSMD1 | RHGGSLGLGLAAMGTARQDVyDLLKTNLYQDDAVTGEAAGL |
| Q99497 | S142 | Sugiyama | PARK7 | KVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGTSF |
| Q99497 | T140 | Sugiyama | PARK7 | GSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGT |
| Q99497 | Y139 | Sugiyama | PARK7 | FGSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPG |
| Q99497 | Y141 | Sugiyama | PARK7 | SKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGTS |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99575 | Y101 | Sugiyama | POP1 KIAA0061 | FRKKGGWKAGPEGTsQEIPKyItAStFAQARAAEISAMLKA |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BPX3 | Y929 | Sugiyama | NCAPG CAPG NYMEL3 | QDATLTTTTFQNEDEKNKEVyMtPLRGVKATQASKSTQLKT |
| Q9BQE3 | Y224 | Sugiyama | TUBA1C TUBA6 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRD0 | Y494 | Sugiyama | BUD13 | KLERLEQRRKAEKDSERDELyAQWGKGLAQSRQQQQNVEDA |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BRL6 | Y44 | Sugiyama | SRSF8 SFRS2B SRP46 | RtsPDsLRRVFEKYGRVGDVyIPREPHTKAPRGFAFVRFHD |
| Q9BS26 | T398 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | VASSPPESSFQKLAPsEyRytLLRDRDEL____________ |
| Q9BS26 | Y397 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | DVASSPPESSFQKLAPsEyRytLLRDRDEL___________ |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BSU3 | Y145 | Sugiyama | NAA11 ARD1B ARD2 | TLNFQISEVEPKyyADGEDAyAMKRDLSQMADELRRQMDLK |
| Q9BUJ2 | Y111 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | GYSGPDGHYAMDNITRQNQFyDtQVIKQENESGyERRPLEM |
| Q9BXS6 | Y370 | Sugiyama | NUSAP1 ANKT BM-037 PRO0310 | PVsNKKPVFDLKAsLsRPLNyEPHKGKLKPWGQSKENNyLN |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9H4E7 | Y210 | EPSD|PSP | DEF6 IBP | SGRCLRGVGRDTLSMAIHEVyQELIQDVLKQGyLWKRGHLR |
| Q9H4E7 | Y222 | EPSD|PSP | DEF6 IBP | LSMAIHEVyQELIQDVLKQGyLWKRGHLRRNWAERWFQLQP |
| Q9H814 | Y309 | Sugiyama | PHAX RNUXA | FLNLLKNtPsISEEQIKDIFyIENQKEYENKKAARKRRTQV |
| Q9H9Y2 | Y287 | Sugiyama | RPF1 BXDC5 | FPHNPQFIGRQVATFHNQRDyIFFRFHRYIFRSEKKVGIQE |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NUL3 | Y326 | Sugiyama | STAU2 | MNPISRLAQIQQAKKEKEPDyVLLSERGMPRRREFVMQVKV |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NVS9 | Y195 | Sugiyama | PNPO | SSVIPDREYLRKKNEELEQLyQDQEVPKPKSWGGYVLYPQV |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NY65 | Y224 | Sugiyama | TUBA8 TUBAL2 | VDNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRF |
| Q9NYB9 | T24 | Sugiyama | ABI2 ARGBPIA | LQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSADKQ |
| Q9NYF8 | Y219 | Sugiyama | BCLAF1 BTF KIAA0164 | IDEFNKssAtsGDIWPGLsAyDNsPRsPHsPsPIAtPPSQS |
| Q9NZB2 | Y9 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | ____________MGVQGFQDyIEKHCPsAVVPVELQKLARG |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y74 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDRNPDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGL |
| Q9UHI6 | Y659 | Sugiyama | DDX20 DP103 GEMIN3 | RVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKsyLEGssD |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UK59 | Y533 | Sugiyama | DBR1 | LsDEHEPEQRKKIKRRNQAIyAAVDDDDDDAA_________ |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9UQ35 | Y2693 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSS |
| Q9Y230 | Y172 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | TGTGSKVGKLTLKTTEMETIyDLGTKMIESLTKDKVQAGDV |
| Q9Y265 | Y438 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | KINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKYMK__ |
| Q9Y281 | T88 | Sugiyama | CFL2 | YtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPES |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y3C1 | Y118 | Sugiyama | NOP16 CGI-117 HSPC111 | EAEASLPEKKGNTLSRDLIDyVRYMVENHGEDYKAMARDEK |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | Y300 | Sugiyama | STRAP MAWD UNRIP | yAsGSEDGTLRLWQTVVGKtyGLWKCVLPEEDsGELAKPKI |
| Q9Y3P9 | Y472 | Sugiyama | RABGAP1 HSPC094 | FFLKLKQIKQRERKNNTDTLyEVVCLESESERERRKTTAsP |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y5Q8 | Y393 | Sugiyama | GTF3C5 CDABP0017 | SGtsGARKPASSKYKLKDSVyIFREGALPPYRQMFYQLCDL |
| Q9Y5R6 | S43 | Sugiyama | DMRT1 DMT1 | PPQGRAGGFGKASGALVGAAsGSSAGGSSRGGGSGSGASDL |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 1.234550e-07 | 6.908 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.585516e-07 | 6.587 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.621140e-07 | 6.582 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.474715e-06 | 5.606 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.152505e-06 | 5.211 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.297765e-06 | 5.201 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.081478e-06 | 5.042 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.464303e-05 | 4.834 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.472631e-05 | 4.832 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.919203e-05 | 4.535 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.804372e-05 | 4.552 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.457345e-05 | 4.351 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.743334e-05 | 4.241 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.109598e-05 | 4.041 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.021663e-04 | 3.991 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.021507e-04 | 3.991 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.753747e-05 | 4.011 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.827749e-05 | 4.008 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.401234e-05 | 4.076 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.404778e-05 | 4.130 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.269363e-04 | 3.896 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.367092e-04 | 3.864 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.752033e-04 | 3.756 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.079223e-04 | 3.682 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.314084e-04 | 3.636 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.314084e-04 | 3.636 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.909276e-04 | 3.536 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.060715e-04 | 3.514 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.761436e-04 | 3.425 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.688722e-04 | 3.433 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.918382e-04 | 3.407 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.419102e-04 | 3.355 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.718129e-04 | 3.326 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.046217e-04 | 3.297 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.690185e-04 | 3.245 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.072941e-04 | 3.217 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.108287e-04 | 3.214 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.852980e-04 | 3.164 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.604410e-04 | 3.119 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.604410e-04 | 3.119 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.604410e-04 | 3.119 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.604410e-04 | 3.119 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.932987e-04 | 3.159 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.211247e-04 | 3.086 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.963514e-04 | 3.099 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.520823e-04 | 3.070 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.739139e-04 | 3.059 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.156089e-04 | 3.038 | 1 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.062245e-03 | 2.974 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.011445e-03 | 2.995 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.045866e-03 | 2.981 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.045866e-03 | 2.981 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.165795e-03 | 2.933 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.174795e-03 | 2.930 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.322239e-03 | 2.879 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.336219e-03 | 2.874 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.386481e-03 | 2.858 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.581488e-03 | 2.801 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.623437e-03 | 2.790 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.730639e-03 | 2.762 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.730639e-03 | 2.762 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.751865e-03 | 2.756 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.890965e-03 | 2.723 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.029565e-03 | 2.693 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.061637e-03 | 2.686 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.114390e-03 | 2.675 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.280700e-03 | 2.642 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.280700e-03 | 2.642 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.336296e-03 | 2.631 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.501011e-03 | 2.602 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.501011e-03 | 2.602 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.673535e-03 | 2.573 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.501011e-03 | 2.602 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.432808e-03 | 2.614 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.787455e-03 | 2.555 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.886030e-03 | 2.540 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.027292e-03 | 2.519 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.039596e-03 | 2.517 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.042734e-03 | 2.517 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.315814e-03 | 2.479 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.315814e-03 | 2.479 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.694297e-03 | 2.432 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.058742e-03 | 2.392 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.114854e-03 | 2.386 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.444310e-03 | 2.352 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.851348e-03 | 2.314 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.867243e-03 | 2.313 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.110336e-03 | 2.292 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.280185e-03 | 2.277 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.417060e-03 | 2.266 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.706913e-03 | 2.244 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.280185e-03 | 2.277 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.078550e-03 | 2.294 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.280185e-03 | 2.277 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.855953e-03 | 2.232 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.204493e-03 | 2.207 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.204493e-03 | 2.207 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.204493e-03 | 2.207 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.204493e-03 | 2.207 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.204493e-03 | 2.207 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.219529e-03 | 2.141 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.638101e-03 | 2.178 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.700537e-03 | 2.174 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.700537e-03 | 2.174 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.311742e-03 | 2.136 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.219529e-03 | 2.141 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.884388e-03 | 2.162 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.638101e-03 | 2.178 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.638101e-03 | 2.178 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.664437e-03 | 2.116 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.761717e-03 | 2.110 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.761717e-03 | 2.110 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.029006e-03 | 2.095 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.327331e-03 | 2.079 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.327331e-03 | 2.079 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.404343e-03 | 2.075 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.460846e-03 | 2.073 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.670040e-03 | 2.062 | 1 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.044038e-02 | 1.981 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.044038e-02 | 1.981 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 9.745723e-03 | 2.011 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 9.745723e-03 | 2.011 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.529687e-03 | 2.021 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.016682e-02 | 1.993 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.016682e-02 | 1.993 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.411235e-03 | 2.026 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.529687e-03 | 2.021 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.598779e-03 | 2.018 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.529687e-03 | 2.021 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.045337e-02 | 1.981 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.077935e-02 | 1.967 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.082815e-02 | 1.965 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.089852e-02 | 1.963 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.105027e-02 | 1.957 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.111153e-02 | 1.954 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.111153e-02 | 1.954 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.111153e-02 | 1.954 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.151385e-02 | 1.939 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.151385e-02 | 1.939 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.222405e-02 | 1.913 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.255646e-02 | 1.901 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.255646e-02 | 1.901 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.255646e-02 | 1.901 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.255646e-02 | 1.901 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.255646e-02 | 1.901 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.255646e-02 | 1.901 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.371851e-02 | 1.863 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.450299e-02 | 1.839 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.255646e-02 | 1.901 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.255646e-02 | 1.901 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.371851e-02 | 1.863 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.450299e-02 | 1.839 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.531243e-02 | 1.815 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.255646e-02 | 1.901 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.407374e-02 | 1.852 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.533790e-02 | 1.814 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.533790e-02 | 1.814 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.546090e-02 | 1.811 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.606548e-02 | 1.794 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.614692e-02 | 1.792 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.614692e-02 | 1.792 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.645613e-02 | 1.784 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.700342e-02 | 1.769 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.700653e-02 | 1.769 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.700653e-02 | 1.769 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 2.077240e-02 | 1.683 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.077240e-02 | 1.683 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.734832e-02 | 1.761 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.734832e-02 | 1.761 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.909221e-02 | 1.719 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.278984e-02 | 1.642 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.278984e-02 | 1.642 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.090660e-02 | 1.680 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.721201e-02 | 1.764 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.789133e-02 | 1.747 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.789133e-02 | 1.747 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.278984e-02 | 1.642 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.278984e-02 | 1.642 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.880136e-02 | 1.726 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.882987e-02 | 1.725 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.168320e-02 | 1.664 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.209254e-02 | 1.656 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.880136e-02 | 1.726 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.909221e-02 | 1.719 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.063668e-02 | 1.685 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.734832e-02 | 1.761 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.168320e-02 | 1.664 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.973261e-02 | 1.705 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.278984e-02 | 1.642 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.090660e-02 | 1.680 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.907449e-02 | 1.720 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.968795e-02 | 1.706 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.914743e-02 | 1.718 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.318859e-02 | 1.635 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.373106e-02 | 1.625 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.392113e-02 | 1.621 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.474031e-02 | 1.607 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.474031e-02 | 1.607 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.474031e-02 | 1.607 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.474031e-02 | 1.607 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.474031e-02 | 1.607 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.479299e-02 | 1.606 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.588022e-02 | 1.587 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.627228e-02 | 1.581 | 1 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.689705e-02 | 1.570 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 2.699090e-02 | 1.569 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.726017e-02 | 1.564 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.813049e-02 | 1.551 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.883662e-02 | 1.540 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.929345e-02 | 1.533 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.944109e-02 | 1.531 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.944109e-02 | 1.531 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.048156e-02 | 1.516 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.058295e-02 | 1.515 | 1 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.097936e-02 | 1.509 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.097936e-02 | 1.509 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.097936e-02 | 1.509 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.097936e-02 | 1.509 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.099717e-02 | 1.509 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.099717e-02 | 1.509 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.099717e-02 | 1.509 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.158718e-02 | 1.500 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 3.169477e-02 | 1.499 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.169477e-02 | 1.499 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.228565e-02 | 1.491 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.318311e-02 | 1.479 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.318311e-02 | 1.479 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.318311e-02 | 1.479 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.014570e-02 | 1.396 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.506582e-02 | 1.346 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.760522e-02 | 1.322 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.971051e-02 | 1.304 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.257604e-02 | 1.371 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.506582e-02 | 1.346 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.971051e-02 | 1.304 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.544639e-02 | 1.450 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.548426e-02 | 1.450 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.014570e-02 | 1.396 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.052707e-02 | 1.392 | 1 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 4.795044e-02 | 1.319 | 1 | 1 |
| Gene Silencing by RNA | R-HSA-211000 | 3.756168e-02 | 1.425 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.506582e-02 | 1.346 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.014570e-02 | 1.396 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.592266e-02 | 1.445 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.760522e-02 | 1.322 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.822955e-02 | 1.418 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.019568e-02 | 1.299 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.679710e-02 | 1.434 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.949677e-02 | 1.403 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.971051e-02 | 1.304 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.949677e-02 | 1.403 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.949677e-02 | 1.403 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.760522e-02 | 1.322 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.497872e-02 | 1.347 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.660201e-02 | 1.436 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.952420e-02 | 1.403 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.506582e-02 | 1.346 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.548426e-02 | 1.450 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.468263e-02 | 1.350 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.863431e-02 | 1.313 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.112940e-02 | 1.291 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.112940e-02 | 1.291 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.126503e-02 | 1.290 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.134747e-02 | 1.289 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.167049e-02 | 1.287 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.198398e-02 | 1.284 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.257030e-02 | 1.279 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.283590e-02 | 1.277 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.388359e-02 | 1.269 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.484840e-02 | 1.261 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.487321e-02 | 1.261 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.552456e-02 | 1.256 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.552456e-02 | 1.256 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.552456e-02 | 1.256 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.552456e-02 | 1.256 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.606853e-02 | 1.251 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.606853e-02 | 1.251 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.738288e-02 | 1.241 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.771581e-02 | 1.239 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.982237e-02 | 1.223 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 6.103903e-02 | 1.214 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.103903e-02 | 1.214 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 6.103903e-02 | 1.214 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.103903e-02 | 1.214 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 6.103903e-02 | 1.214 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 6.103903e-02 | 1.214 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.103903e-02 | 1.214 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.104207e-02 | 1.214 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.104207e-02 | 1.214 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.292657e-02 | 1.201 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.359632e-02 | 1.197 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.386841e-02 | 1.195 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.386841e-02 | 1.195 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.504156e-02 | 1.187 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.523526e-02 | 1.186 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.551772e-02 | 1.184 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.622335e-02 | 1.179 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.629043e-02 | 1.179 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.629043e-02 | 1.179 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.629043e-02 | 1.179 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.673818e-02 | 1.176 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.807175e-02 | 1.167 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.807175e-02 | 1.167 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.084578e-02 | 1.150 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.084578e-02 | 1.150 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 7.084578e-02 | 1.150 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 8.055070e-02 | 1.094 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 8.055070e-02 | 1.094 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.015485e-02 | 1.045 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.015485e-02 | 1.045 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.015485e-02 | 1.045 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.965926e-02 | 1.001 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.965926e-02 | 1.001 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 9.965926e-02 | 1.001 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.090650e-01 | 0.962 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.090650e-01 | 0.962 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.090650e-01 | 0.962 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.090650e-01 | 0.962 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.183730e-01 | 0.927 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.183730e-01 | 0.927 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.183730e-01 | 0.927 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.183730e-01 | 0.927 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.275844e-01 | 0.894 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.367000e-01 | 0.864 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.367000e-01 | 0.864 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.367000e-01 | 0.864 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.367000e-01 | 0.864 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.367000e-01 | 0.864 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.367000e-01 | 0.864 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.965018e-02 | 1.157 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.756940e-02 | 1.011 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.350737e-01 | 0.869 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.306601e-01 | 0.884 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.330146e-01 | 0.876 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.704548e-02 | 1.060 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 9.965926e-02 | 1.001 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.111947e-02 | 1.040 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.084578e-02 | 1.150 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.055070e-02 | 1.094 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.041444e-01 | 0.982 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.168577e-01 | 0.932 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.090650e-01 | 0.962 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.236879e-01 | 0.908 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.236879e-01 | 0.908 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.123863e-01 | 0.949 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 7.084578e-02 | 1.150 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 7.084578e-02 | 1.150 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.315408e-01 | 0.881 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.330146e-01 | 0.876 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.210777e-01 | 0.917 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.015485e-02 | 1.045 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 7.084578e-02 | 1.150 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 8.055070e-02 | 1.094 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 8.055070e-02 | 1.094 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.090650e-01 | 0.962 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 1.275844e-01 | 0.894 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.367000e-01 | 0.864 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 9.965926e-02 | 1.001 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.275844e-01 | 0.894 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.354509e-02 | 1.133 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.965926e-02 | 1.001 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.538379e-02 | 1.021 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.219940e-02 | 1.085 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.260321e-02 | 1.139 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.090650e-01 | 0.962 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.183730e-01 | 0.927 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.367000e-01 | 0.864 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.068141e-01 | 0.971 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.210777e-01 | 0.917 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.457162e-02 | 1.073 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.457162e-02 | 1.073 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.457162e-02 | 1.073 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.607738e-02 | 1.065 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.079827e-01 | 0.967 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.015485e-02 | 1.045 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.214709e-02 | 1.142 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.090650e-01 | 0.962 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.315408e-01 | 0.881 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.765988e-02 | 1.010 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.794394e-02 | 1.056 | 1 | 1 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.111947e-02 | 1.040 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.260321e-02 | 1.139 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.300387e-02 | 1.137 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.315408e-01 | 0.881 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.111947e-02 | 1.040 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.559611e-02 | 1.122 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.888923e-02 | 1.162 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.756940e-02 | 1.011 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.058069e-01 | 0.975 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.275844e-01 | 0.894 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.008418e-01 | 0.996 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.168577e-01 | 0.932 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.410976e-02 | 1.130 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.367000e-01 | 0.864 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.905441e-02 | 1.050 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.183730e-01 | 0.927 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.589335e-02 | 1.066 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.018415e-01 | 0.992 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.260321e-02 | 1.139 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.169701e-02 | 1.088 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.704548e-02 | 1.060 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.068141e-01 | 0.971 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.480276e-02 | 1.072 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.386278e-01 | 0.858 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.407231e-01 | 0.852 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.422023e-01 | 0.847 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.457210e-01 | 0.836 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.457210e-01 | 0.836 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.457210e-01 | 0.836 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.457963e-01 | 0.836 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.457963e-01 | 0.836 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.494092e-01 | 0.826 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.494092e-01 | 0.826 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.530400e-01 | 0.815 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.546483e-01 | 0.811 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.546483e-01 | 0.811 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 1.546483e-01 | 0.811 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.546483e-01 | 0.811 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.546483e-01 | 0.811 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.566881e-01 | 0.805 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.573366e-01 | 0.803 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.573366e-01 | 0.803 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.603527e-01 | 0.795 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.603527e-01 | 0.795 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.603527e-01 | 0.795 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.603527e-01 | 0.795 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.603527e-01 | 0.795 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.634828e-01 | 0.787 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.634828e-01 | 0.787 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.634828e-01 | 0.787 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.634828e-01 | 0.787 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.634828e-01 | 0.787 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.634828e-01 | 0.787 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.634828e-01 | 0.787 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.634828e-01 | 0.787 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.634828e-01 | 0.787 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.640331e-01 | 0.785 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.648872e-01 | 0.783 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.714382e-01 | 0.766 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.714382e-01 | 0.766 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.722255e-01 | 0.764 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.722255e-01 | 0.764 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.722255e-01 | 0.764 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.722255e-01 | 0.764 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.722255e-01 | 0.764 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 1.722255e-01 | 0.764 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.722255e-01 | 0.764 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.722255e-01 | 0.764 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.722255e-01 | 0.764 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.767245e-01 | 0.753 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.783195e-01 | 0.749 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 1.808774e-01 | 0.743 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.808774e-01 | 0.743 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.808774e-01 | 0.743 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.808774e-01 | 0.743 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.808774e-01 | 0.743 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.808774e-01 | 0.743 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.808774e-01 | 0.743 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.808774e-01 | 0.743 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.808774e-01 | 0.743 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.808774e-01 | 0.743 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.826465e-01 | 0.738 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.881494e-01 | 0.725 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.894394e-01 | 0.723 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.894394e-01 | 0.723 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.894394e-01 | 0.723 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.894394e-01 | 0.723 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.894394e-01 | 0.723 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.894394e-01 | 0.723 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.894394e-01 | 0.723 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.894394e-01 | 0.723 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.894394e-01 | 0.723 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.894394e-01 | 0.723 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.901779e-01 | 0.721 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.977507e-01 | 0.704 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.979125e-01 | 0.704 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.979125e-01 | 0.704 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.979125e-01 | 0.704 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.979125e-01 | 0.704 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.979125e-01 | 0.704 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.979125e-01 | 0.704 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.015510e-01 | 0.696 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.015510e-01 | 0.696 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.053599e-01 | 0.687 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.053599e-01 | 0.687 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.053599e-01 | 0.687 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.062975e-01 | 0.686 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.062975e-01 | 0.686 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.062975e-01 | 0.686 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.062975e-01 | 0.686 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.070036e-01 | 0.684 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.091767e-01 | 0.679 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.091767e-01 | 0.679 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.107091e-01 | 0.676 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.107091e-01 | 0.676 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.130008e-01 | 0.672 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.130008e-01 | 0.672 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.145953e-01 | 0.668 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.145953e-01 | 0.668 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.145953e-01 | 0.668 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.145953e-01 | 0.668 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 2.145953e-01 | 0.668 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.168317e-01 | 0.664 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.168317e-01 | 0.664 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.206689e-01 | 0.656 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.228069e-01 | 0.652 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.228069e-01 | 0.652 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.228069e-01 | 0.652 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.228069e-01 | 0.652 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.228069e-01 | 0.652 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.228069e-01 | 0.652 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.228069e-01 | 0.652 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.228069e-01 | 0.652 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.228069e-01 | 0.652 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.258369e-01 | 0.646 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.299403e-01 | 0.638 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.309331e-01 | 0.637 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.309331e-01 | 0.637 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.309331e-01 | 0.637 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.309331e-01 | 0.637 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.309331e-01 | 0.637 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.309331e-01 | 0.637 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 2.309331e-01 | 0.637 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 2.309331e-01 | 0.637 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.309331e-01 | 0.637 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.389749e-01 | 0.622 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.389749e-01 | 0.622 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.389749e-01 | 0.622 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.389749e-01 | 0.622 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.389749e-01 | 0.622 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.394841e-01 | 0.621 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.535866e-01 | 0.596 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.548085e-01 | 0.594 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.548085e-01 | 0.594 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.548085e-01 | 0.594 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.548085e-01 | 0.594 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.553970e-01 | 0.593 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.592682e-01 | 0.586 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.592682e-01 | 0.586 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.626021e-01 | 0.581 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.626021e-01 | 0.581 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.626021e-01 | 0.581 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.626021e-01 | 0.581 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.626021e-01 | 0.581 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.626021e-01 | 0.581 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.631402e-01 | 0.580 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.670126e-01 | 0.573 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.703146e-01 | 0.568 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.703146e-01 | 0.568 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.703146e-01 | 0.568 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.703146e-01 | 0.568 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.708849e-01 | 0.567 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.708849e-01 | 0.567 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.779470e-01 | 0.556 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.779470e-01 | 0.556 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.779470e-01 | 0.556 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.779470e-01 | 0.556 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.779470e-01 | 0.556 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.824972e-01 | 0.549 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.847461e-01 | 0.546 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.854999e-01 | 0.544 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.854999e-01 | 0.544 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.854999e-01 | 0.544 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.854999e-01 | 0.544 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.854999e-01 | 0.544 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.863652e-01 | 0.543 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.863652e-01 | 0.543 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.902311e-01 | 0.537 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.929744e-01 | 0.533 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.929744e-01 | 0.533 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.929744e-01 | 0.533 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.929744e-01 | 0.533 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.929744e-01 | 0.533 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 2.929744e-01 | 0.533 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 2.929744e-01 | 0.533 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.940945e-01 | 0.532 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.968034e-01 | 0.528 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.988599e-01 | 0.525 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 3.003711e-01 | 0.522 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.003711e-01 | 0.522 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.018126e-01 | 0.520 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.056665e-01 | 0.515 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.056665e-01 | 0.515 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.076908e-01 | 0.512 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 3.076908e-01 | 0.512 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.095165e-01 | 0.509 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.149345e-01 | 0.502 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 3.216972e-01 | 0.493 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 3.221027e-01 | 0.492 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.286971e-01 | 0.483 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.325171e-01 | 0.478 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.362164e-01 | 0.473 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.362164e-01 | 0.473 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.362164e-01 | 0.473 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.362164e-01 | 0.473 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.362164e-01 | 0.473 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.362164e-01 | 0.473 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.362164e-01 | 0.473 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.363310e-01 | 0.473 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.401385e-01 | 0.468 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.401385e-01 | 0.468 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.408139e-01 | 0.467 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.431633e-01 | 0.464 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.500379e-01 | 0.456 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.500379e-01 | 0.456 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.568410e-01 | 0.448 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.568410e-01 | 0.448 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.590708e-01 | 0.445 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.628344e-01 | 0.440 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.635733e-01 | 0.439 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.635733e-01 | 0.439 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 3.635733e-01 | 0.439 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.635733e-01 | 0.439 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.635733e-01 | 0.439 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.645032e-01 | 0.438 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.687964e-01 | 0.433 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.701880e-01 | 0.432 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.702355e-01 | 0.432 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.702355e-01 | 0.432 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.702355e-01 | 0.432 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.702355e-01 | 0.432 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.740749e-01 | 0.427 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.740749e-01 | 0.427 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.768284e-01 | 0.424 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 3.833527e-01 | 0.416 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.833527e-01 | 0.416 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.843589e-01 | 0.415 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.871849e-01 | 0.412 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.898091e-01 | 0.409 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.926281e-01 | 0.406 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.928281e-01 | 0.406 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.010539e-01 | 0.397 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 4.025209e-01 | 0.395 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 4.087778e-01 | 0.389 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.145613e-01 | 0.382 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.149695e-01 | 0.382 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.149695e-01 | 0.382 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.180488e-01 | 0.379 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.210967e-01 | 0.376 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.210967e-01 | 0.376 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.253811e-01 | 0.371 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.271602e-01 | 0.369 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.325369e-01 | 0.364 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.331605e-01 | 0.363 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.331605e-01 | 0.363 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.331605e-01 | 0.363 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.331605e-01 | 0.363 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.331605e-01 | 0.363 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.331605e-01 | 0.363 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.390983e-01 | 0.357 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 4.390983e-01 | 0.357 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.431814e-01 | 0.353 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.449743e-01 | 0.352 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.507891e-01 | 0.346 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.507891e-01 | 0.346 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.511296e-01 | 0.346 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.538533e-01 | 0.343 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 4.564739e-01 | 0.341 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.565433e-01 | 0.341 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.565433e-01 | 0.341 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.678726e-01 | 0.330 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.678726e-01 | 0.330 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.678726e-01 | 0.330 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.734489e-01 | 0.325 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.734489e-01 | 0.325 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.734489e-01 | 0.325 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.734489e-01 | 0.325 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.778486e-01 | 0.321 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.789671e-01 | 0.320 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.789671e-01 | 0.320 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.793207e-01 | 0.319 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.834325e-01 | 0.316 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.844278e-01 | 0.315 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.844278e-01 | 0.315 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.846247e-01 | 0.315 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.879925e-01 | 0.312 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.898316e-01 | 0.310 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.898316e-01 | 0.310 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.898316e-01 | 0.310 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.951791e-01 | 0.305 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.004709e-01 | 0.301 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.004709e-01 | 0.301 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.004709e-01 | 0.301 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.046250e-01 | 0.297 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.057075e-01 | 0.296 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.057075e-01 | 0.296 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.057075e-01 | 0.296 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.057075e-01 | 0.296 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.079097e-01 | 0.294 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 5.108895e-01 | 0.292 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.160176e-01 | 0.287 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.176789e-01 | 0.286 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.209068e-01 | 0.283 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.210922e-01 | 0.283 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.210922e-01 | 0.283 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.261139e-01 | 0.279 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.273195e-01 | 0.278 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.310832e-01 | 0.275 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.336743e-01 | 0.273 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.336743e-01 | 0.273 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.399710e-01 | 0.268 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.401894e-01 | 0.267 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.430975e-01 | 0.265 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.430975e-01 | 0.265 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.432976e-01 | 0.265 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.456826e-01 | 0.263 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.456826e-01 | 0.263 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.483430e-01 | 0.261 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.493063e-01 | 0.260 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.493063e-01 | 0.260 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.504479e-01 | 0.259 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.504479e-01 | 0.259 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.523886e-01 | 0.258 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.523886e-01 | 0.258 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.566570e-01 | 0.254 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.585089e-01 | 0.253 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.585089e-01 | 0.253 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.598300e-01 | 0.252 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.644478e-01 | 0.248 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.644478e-01 | 0.248 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.644478e-01 | 0.248 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.705713e-01 | 0.244 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.735394e-01 | 0.241 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 5.766518e-01 | 0.239 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.798700e-01 | 0.237 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.824423e-01 | 0.235 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.824423e-01 | 0.235 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.853431e-01 | 0.233 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.911060e-01 | 0.228 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.911605e-01 | 0.228 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.954514e-01 | 0.225 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.996976e-01 | 0.222 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.160262e-01 | 0.210 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.164289e-01 | 0.210 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.202731e-01 | 0.207 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.242603e-01 | 0.205 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.282058e-01 | 0.202 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 6.282973e-01 | 0.202 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.359738e-01 | 0.197 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.405404e-01 | 0.193 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.473242e-01 | 0.189 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.483101e-01 | 0.188 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.508705e-01 | 0.187 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.654649e-01 | 0.177 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.654649e-01 | 0.177 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.689802e-01 | 0.175 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.724587e-01 | 0.172 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.756687e-01 | 0.170 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.759009e-01 | 0.170 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.759009e-01 | 0.170 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.793071e-01 | 0.168 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.805742e-01 | 0.167 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.826778e-01 | 0.166 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.875251e-01 | 0.163 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.958118e-01 | 0.158 | 0 | 0 |
| Translation | R-HSA-72766 | 6.976886e-01 | 0.156 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.012836e-01 | 0.154 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.012836e-01 | 0.154 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.053064e-01 | 0.152 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.084053e-01 | 0.150 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.084053e-01 | 0.150 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.114718e-01 | 0.148 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.145063e-01 | 0.146 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.175090e-01 | 0.144 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.209807e-01 | 0.142 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.234206e-01 | 0.141 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.234206e-01 | 0.141 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.292092e-01 | 0.137 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.376671e-01 | 0.132 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.404276e-01 | 0.131 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.431592e-01 | 0.129 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.435666e-01 | 0.129 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.458623e-01 | 0.127 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.485371e-01 | 0.126 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.485371e-01 | 0.126 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.589592e-01 | 0.120 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.589592e-01 | 0.120 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.640081e-01 | 0.117 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.716901e-01 | 0.113 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.737926e-01 | 0.111 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.877182e-01 | 0.104 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.899549e-01 | 0.102 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.986651e-01 | 0.098 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.986651e-01 | 0.098 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.989896e-01 | 0.097 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.028910e-01 | 0.095 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.028910e-01 | 0.095 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.318699e-01 | 0.080 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.518399e-01 | 0.070 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.581241e-01 | 0.066 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.581241e-01 | 0.066 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.600047e-01 | 0.065 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.682880e-01 | 0.061 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.682880e-01 | 0.061 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.710566e-01 | 0.060 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.770234e-01 | 0.057 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.828166e-01 | 0.054 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.850200e-01 | 0.053 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.888826e-01 | 0.051 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.011512e-01 | 0.045 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.042568e-01 | 0.044 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.192533e-01 | 0.037 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.353902e-01 | 0.029 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.407293e-01 | 0.027 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.481743e-01 | 0.023 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.504256e-01 | 0.022 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.526362e-01 | 0.021 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.574380e-01 | 0.019 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.645158e-01 | 0.016 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.656198e-01 | 0.015 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.739927e-01 | 0.011 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.783291e-01 | 0.010 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.969963e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.985608e-01 | 0.001 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999898e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.331468e-15 | 14.632 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.287859e-14 | 13.890 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.487699e-14 | 13.827 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.808065e-14 | 13.419 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.628831e-14 | 13.250 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.327472e-14 | 13.135 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.570122e-14 | 13.019 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.032818e-13 | 12.692 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.032818e-13 | 12.692 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.066125e-13 | 12.685 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.297051e-13 | 12.639 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.809175e-13 | 12.419 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.963008e-13 | 12.225 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.857537e-13 | 12.232 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.685763e-13 | 12.175 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.075762e-13 | 12.093 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.075762e-13 | 12.093 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.148238e-13 | 12.039 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.205924e-12 | 11.919 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.748934e-12 | 11.757 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.051026e-12 | 11.688 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.876721e-12 | 11.727 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.051026e-12 | 11.688 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.398171e-12 | 11.469 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.334533e-12 | 11.363 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.334533e-12 | 11.363 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.826251e-12 | 11.316 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.163092e-12 | 11.287 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.497602e-12 | 11.260 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.577538e-12 | 11.254 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.064460e-12 | 11.151 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.064460e-12 | 11.151 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.702816e-12 | 11.060 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.702816e-12 | 11.060 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.086697e-11 | 10.964 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.086697e-11 | 10.964 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.665512e-11 | 10.778 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.670597e-11 | 10.777 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.670597e-11 | 10.777 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.057543e-11 | 10.687 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.433909e-11 | 10.614 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.523404e-11 | 10.598 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.687262e-11 | 10.571 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.082190e-11 | 10.511 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.082190e-11 | 10.511 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.095124e-11 | 10.509 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.097378e-11 | 10.509 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.379086e-11 | 10.471 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.381506e-11 | 10.471 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.381506e-11 | 10.471 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.545297e-11 | 10.342 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.489276e-11 | 10.260 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.057943e-11 | 10.218 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.606082e-11 | 10.180 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.008187e-10 | 9.996 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.128775e-10 | 9.947 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.325167e-10 | 9.878 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.526488e-10 | 9.816 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.588552e-10 | 9.799 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.866722e-10 | 9.729 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.876347e-10 | 9.727 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.954621e-10 | 9.709 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.104132e-10 | 9.677 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.283045e-10 | 9.641 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.670422e-10 | 9.573 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.974710e-10 | 9.527 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.042107e-10 | 9.517 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.154927e-10 | 9.501 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.555403e-10 | 9.449 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.057366e-10 | 9.392 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.145138e-10 | 9.382 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.036256e-10 | 9.298 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.066887e-10 | 9.295 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.102480e-10 | 9.292 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.704350e-10 | 9.244 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.285961e-10 | 9.138 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.925227e-10 | 9.003 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.139569e-09 | 8.943 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.165889e-09 | 8.933 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.208218e-09 | 8.918 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.311101e-09 | 8.882 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.420650e-09 | 8.848 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.648161e-09 | 8.783 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.705038e-09 | 8.768 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.695285e-09 | 8.771 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.888871e-09 | 8.724 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.705038e-09 | 8.768 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.942974e-09 | 8.712 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.334062e-09 | 8.632 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.544686e-09 | 8.594 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.145415e-09 | 8.502 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.639321e-09 | 8.439 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.970620e-09 | 8.401 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.285652e-09 | 8.368 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.625764e-09 | 8.335 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.730298e-09 | 8.325 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.844702e-09 | 8.233 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.844702e-09 | 8.233 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.240612e-09 | 8.281 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.119357e-09 | 8.213 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.555706e-09 | 8.183 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.034258e-09 | 8.153 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.286758e-08 | 7.891 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.750099e-08 | 7.757 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.923466e-08 | 7.716 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.128015e-08 | 7.672 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.212870e-08 | 7.655 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.296282e-08 | 7.639 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.562638e-08 | 7.591 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.985991e-08 | 7.525 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.169815e-08 | 7.380 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.681592e-08 | 7.434 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.660415e-08 | 7.436 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.790393e-08 | 7.421 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.824053e-08 | 7.317 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.445402e-08 | 7.264 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.646687e-08 | 7.248 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.048959e-08 | 7.152 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.116949e-08 | 7.148 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.116949e-08 | 7.148 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.116949e-08 | 7.148 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.215214e-08 | 7.142 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.215214e-08 | 7.142 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.915805e-08 | 7.102 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.458260e-08 | 7.073 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.355344e-08 | 7.029 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.355344e-08 | 7.029 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.773637e-08 | 7.010 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.896430e-08 | 7.005 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.707063e-07 | 6.768 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.954085e-07 | 6.709 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.054722e-07 | 6.687 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.357458e-07 | 6.628 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.651122e-07 | 6.577 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.691518e-07 | 6.570 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.756095e-07 | 6.560 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.921745e-07 | 6.534 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.142863e-07 | 6.383 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.512886e-07 | 6.346 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.725317e-07 | 6.326 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.779916e-07 | 6.321 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.139900e-07 | 6.289 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.330382e-07 | 6.273 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.844029e-07 | 6.233 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.208295e-07 | 6.207 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.997871e-07 | 6.155 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.487769e-07 | 6.126 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.806710e-07 | 6.108 | 1 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.890219e-07 | 6.103 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.170728e-07 | 6.088 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.670567e-07 | 6.062 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.758225e-07 | 6.058 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.933996e-07 | 6.003 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.061893e-06 | 5.974 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.139868e-06 | 5.943 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.153208e-06 | 5.938 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.153208e-06 | 5.938 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.342398e-06 | 5.872 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.549043e-06 | 5.810 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.585038e-06 | 5.800 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.223014e-06 | 5.653 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.135255e-06 | 5.671 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.336119e-06 | 5.632 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.336119e-06 | 5.632 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.526541e-06 | 5.597 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.526541e-06 | 5.597 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.763337e-06 | 5.559 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.810023e-06 | 5.551 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.940692e-06 | 5.532 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.250038e-06 | 5.488 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.413490e-06 | 5.467 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.258376e-06 | 5.371 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.775227e-06 | 5.321 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.881997e-06 | 5.311 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.917704e-06 | 5.160 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.969566e-06 | 5.157 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.016887e-06 | 5.154 | 1 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.208750e-06 | 5.142 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.601891e-06 | 5.119 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.832715e-06 | 5.007 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.261328e-05 | 4.899 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.385158e-05 | 4.859 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.445938e-05 | 4.840 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.673380e-05 | 4.776 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.673380e-05 | 4.776 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.673380e-05 | 4.776 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.791217e-05 | 4.747 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.821450e-05 | 4.740 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.860712e-05 | 4.730 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.174665e-05 | 4.663 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.788177e-05 | 4.555 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.977830e-05 | 4.526 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.985411e-05 | 4.525 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.064641e-05 | 4.514 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.161655e-05 | 4.500 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.838347e-05 | 4.416 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.900482e-05 | 4.409 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.136958e-05 | 4.383 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.306522e-05 | 4.366 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.357149e-05 | 4.361 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.469861e-05 | 4.350 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.946655e-05 | 4.306 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.652771e-05 | 4.177 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.652771e-05 | 4.177 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.995949e-05 | 4.301 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.652771e-05 | 4.177 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.291642e-05 | 4.276 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.996524e-05 | 4.155 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.042673e-05 | 4.095 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.458189e-05 | 4.073 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.027245e-04 | 3.988 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.170011e-04 | 3.932 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.311524e-04 | 3.882 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.325098e-04 | 3.878 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.373782e-04 | 3.862 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.380329e-04 | 3.860 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.447955e-04 | 3.839 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.811304e-04 | 3.742 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.811304e-04 | 3.742 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.858267e-04 | 3.731 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.997192e-04 | 3.700 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.372606e-04 | 3.625 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.643537e-04 | 3.578 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.693899e-04 | 3.570 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.250456e-04 | 3.488 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.264876e-04 | 3.486 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.469186e-04 | 3.460 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.495667e-04 | 3.456 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.689692e-04 | 3.433 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.689692e-04 | 3.433 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.689692e-04 | 3.433 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.689692e-04 | 3.433 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.763219e-04 | 3.424 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.806394e-04 | 3.419 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.021683e-04 | 3.396 | 0 | 0 |
| Translation | R-HSA-72766 | 5.315846e-04 | 3.274 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.349475e-04 | 3.272 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.420439e-04 | 3.266 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.379621e-04 | 3.195 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.463056e-04 | 3.190 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.678989e-04 | 3.175 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.859120e-04 | 3.164 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.412032e-04 | 3.130 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.610516e-04 | 3.119 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.045716e-04 | 3.044 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.378322e-04 | 3.028 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.865969e-04 | 3.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.115850e-03 | 2.952 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.122652e-03 | 2.950 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.201434e-03 | 2.920 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.260344e-03 | 2.900 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.301245e-03 | 2.886 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.301245e-03 | 2.886 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.465929e-03 | 2.834 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.661563e-03 | 2.779 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.747623e-03 | 2.758 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.764530e-03 | 2.753 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.814798e-03 | 2.741 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.829543e-03 | 2.738 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.829543e-03 | 2.738 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.035795e-03 | 2.691 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.234701e-03 | 2.651 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.244763e-03 | 2.649 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.277095e-03 | 2.643 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.447843e-03 | 2.611 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.747431e-03 | 2.561 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.815362e-03 | 2.550 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.747431e-03 | 2.561 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.330133e-03 | 2.478 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.717336e-03 | 2.566 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.350453e-03 | 2.475 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.677179e-03 | 2.434 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.046375e-03 | 2.516 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.615684e-03 | 2.442 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.525588e-03 | 2.453 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.268994e-03 | 2.370 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.402837e-03 | 2.356 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.574832e-03 | 2.340 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.609629e-03 | 2.336 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.930799e-03 | 2.307 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.649925e-03 | 2.248 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.649925e-03 | 2.248 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.835196e-03 | 2.234 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.008332e-03 | 2.221 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.091700e-03 | 2.215 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.019310e-03 | 2.096 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.234712e-03 | 2.084 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 9.343968e-03 | 2.029 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.052686e-02 | 1.978 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.075904e-02 | 1.968 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.099331e-02 | 1.959 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.099331e-02 | 1.959 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.099331e-02 | 1.959 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.099331e-02 | 1.959 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.099331e-02 | 1.959 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.099331e-02 | 1.959 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.127079e-02 | 1.948 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.226241e-02 | 1.911 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.244220e-02 | 1.905 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.244757e-02 | 1.905 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.244757e-02 | 1.905 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.244757e-02 | 1.905 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.316357e-02 | 1.881 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.351073e-02 | 1.869 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.385197e-02 | 1.858 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.471443e-02 | 1.832 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.487274e-02 | 1.828 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.531418e-02 | 1.815 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.663162e-02 | 1.779 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.682197e-02 | 1.774 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.911751e-02 | 1.719 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.930015e-02 | 1.714 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.947943e-02 | 1.710 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.103168e-02 | 1.677 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.103168e-02 | 1.677 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.168867e-02 | 1.664 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.478716e-02 | 1.606 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.508692e-02 | 1.601 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.515229e-02 | 1.599 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 2.635752e-02 | 1.579 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.722425e-02 | 1.565 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.722425e-02 | 1.565 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.841626e-02 | 1.546 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.865712e-02 | 1.543 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.943228e-02 | 1.531 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.953857e-02 | 1.530 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.077059e-02 | 1.512 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.079630e-02 | 1.512 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.170921e-02 | 1.499 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.262070e-02 | 1.487 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.340756e-02 | 1.476 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.405327e-02 | 1.468 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.416970e-02 | 1.466 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.646275e-02 | 1.438 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.646275e-02 | 1.438 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.652068e-02 | 1.437 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.893592e-02 | 1.410 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.893592e-02 | 1.410 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.980701e-02 | 1.400 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.073896e-02 | 1.390 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.147112e-02 | 1.382 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.325737e-02 | 1.364 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.325737e-02 | 1.364 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.325737e-02 | 1.364 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.325737e-02 | 1.364 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.325737e-02 | 1.364 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.335629e-02 | 1.363 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.335629e-02 | 1.363 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.513527e-02 | 1.345 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.599108e-02 | 1.337 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.632990e-02 | 1.334 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.418307e-02 | 1.193 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.447461e-02 | 1.128 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 7.447461e-02 | 1.128 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.465360e-02 | 1.072 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.465360e-02 | 1.072 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.472126e-02 | 1.024 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 9.472126e-02 | 1.024 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.219970e-02 | 1.282 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.300114e-02 | 1.137 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.891038e-02 | 1.051 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.988624e-02 | 1.156 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.988624e-02 | 1.156 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.260489e-02 | 1.083 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.592437e-02 | 1.018 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.465360e-02 | 1.072 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.760976e-02 | 1.011 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.760976e-02 | 1.011 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.760976e-02 | 1.011 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.201458e-02 | 1.208 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.377774e-02 | 1.269 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.465360e-02 | 1.072 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.219970e-02 | 1.282 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.936179e-02 | 1.100 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.808345e-02 | 1.236 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.808345e-02 | 1.236 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.091502e-02 | 1.149 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.260489e-02 | 1.083 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.596611e-02 | 1.018 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.832586e-02 | 1.106 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 7.447461e-02 | 1.128 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.447461e-02 | 1.128 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.472126e-02 | 1.024 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.465360e-02 | 1.072 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.472126e-02 | 1.024 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.379405e-02 | 1.195 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.921023e-02 | 1.050 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.289213e-02 | 1.137 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.920301e-02 | 1.050 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.716776e-02 | 1.243 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.988624e-02 | 1.156 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.588812e-02 | 1.066 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.294063e-02 | 1.276 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.921023e-02 | 1.050 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.235275e-02 | 1.205 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.499109e-02 | 1.071 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.616010e-02 | 1.118 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.081956e-02 | 1.216 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.260489e-02 | 1.083 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.260489e-02 | 1.083 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.256996e-02 | 1.034 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.808345e-02 | 1.236 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.071892e-02 | 1.295 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.788317e-02 | 1.009 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.939747e-02 | 1.003 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.042364e-01 | 0.982 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.046788e-01 | 0.980 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.046788e-01 | 0.980 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.046788e-01 | 0.980 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.046788e-01 | 0.980 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.063612e-01 | 0.973 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.084514e-01 | 0.965 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 1.091925e-01 | 0.962 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.098912e-01 | 0.959 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.098912e-01 | 0.959 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.134519e-01 | 0.945 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.134519e-01 | 0.945 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.170422e-01 | 0.932 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 1.226169e-01 | 0.911 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.233930e-01 | 0.909 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.242683e-01 | 0.906 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.242683e-01 | 0.906 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.242683e-01 | 0.906 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.242683e-01 | 0.906 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.242683e-01 | 0.906 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.242683e-01 | 0.906 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.242683e-01 | 0.906 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.258227e-01 | 0.900 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.279797e-01 | 0.893 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.316777e-01 | 0.880 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.316777e-01 | 0.880 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.316777e-01 | 0.880 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.339027e-01 | 0.873 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.339027e-01 | 0.873 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.339027e-01 | 0.873 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.339027e-01 | 0.873 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.339027e-01 | 0.873 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.339027e-01 | 0.873 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.357113e-01 | 0.867 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.360521e-01 | 0.866 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.401446e-01 | 0.853 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.429141e-01 | 0.845 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.429141e-01 | 0.845 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.429141e-01 | 0.845 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.434316e-01 | 0.843 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.434316e-01 | 0.843 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.458582e-01 | 0.836 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.458582e-01 | 0.836 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.467039e-01 | 0.834 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.467039e-01 | 0.834 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.505143e-01 | 0.822 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.528563e-01 | 0.816 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.536273e-01 | 0.814 | 1 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.543444e-01 | 0.812 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.581933e-01 | 0.801 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.581933e-01 | 0.801 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.620602e-01 | 0.790 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.620602e-01 | 0.790 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 1.621778e-01 | 0.790 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 1.621778e-01 | 0.790 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.621778e-01 | 0.790 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.621778e-01 | 0.790 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.621778e-01 | 0.790 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.621778e-01 | 0.790 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.621778e-01 | 0.790 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.641838e-01 | 0.785 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.713974e-01 | 0.766 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.713974e-01 | 0.766 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.713974e-01 | 0.766 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.713974e-01 | 0.766 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.713974e-01 | 0.766 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.713974e-01 | 0.766 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.737600e-01 | 0.760 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.776725e-01 | 0.750 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.804066e-01 | 0.744 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.805160e-01 | 0.743 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.805160e-01 | 0.743 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.805160e-01 | 0.743 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.805160e-01 | 0.743 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.805160e-01 | 0.743 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.805160e-01 | 0.743 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.805160e-01 | 0.743 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.855917e-01 | 0.731 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.886768e-01 | 0.724 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.895349e-01 | 0.722 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.895349e-01 | 0.722 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.895349e-01 | 0.722 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.895349e-01 | 0.722 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.895349e-01 | 0.722 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.942441e-01 | 0.712 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.970432e-01 | 0.705 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 1.984550e-01 | 0.702 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.984550e-01 | 0.702 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.984550e-01 | 0.702 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.984550e-01 | 0.702 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.984550e-01 | 0.702 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.984550e-01 | 0.702 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.053638e-01 | 0.687 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.055478e-01 | 0.687 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 2.072776e-01 | 0.683 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 2.072776e-01 | 0.683 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.072776e-01 | 0.683 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.072776e-01 | 0.683 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.135964e-01 | 0.670 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.160035e-01 | 0.666 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.160035e-01 | 0.666 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.160035e-01 | 0.666 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.160035e-01 | 0.666 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.176321e-01 | 0.662 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.216746e-01 | 0.654 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.246340e-01 | 0.649 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.246340e-01 | 0.649 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.257232e-01 | 0.646 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.331699e-01 | 0.632 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.331699e-01 | 0.632 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.331699e-01 | 0.632 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.331699e-01 | 0.632 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.331699e-01 | 0.632 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.371396e-01 | 0.625 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.378997e-01 | 0.624 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.412071e-01 | 0.618 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.412071e-01 | 0.618 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.416125e-01 | 0.617 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.416125e-01 | 0.617 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.416125e-01 | 0.617 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.416125e-01 | 0.617 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.460370e-01 | 0.609 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.460370e-01 | 0.609 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.460370e-01 | 0.609 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.488722e-01 | 0.604 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.499625e-01 | 0.602 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.499625e-01 | 0.602 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.499625e-01 | 0.602 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.582212e-01 | 0.588 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 2.582212e-01 | 0.588 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.582212e-01 | 0.588 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.606784e-01 | 0.584 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.663894e-01 | 0.574 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.663894e-01 | 0.574 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.663894e-01 | 0.574 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.744682e-01 | 0.562 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.744682e-01 | 0.562 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.744682e-01 | 0.562 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.744682e-01 | 0.562 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.744682e-01 | 0.562 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.786484e-01 | 0.555 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.786901e-01 | 0.555 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.824585e-01 | 0.549 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.824585e-01 | 0.549 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.824585e-01 | 0.549 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.824585e-01 | 0.549 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.824585e-01 | 0.549 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.827234e-01 | 0.549 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.844932e-01 | 0.546 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.874847e-01 | 0.541 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.903613e-01 | 0.537 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.903613e-01 | 0.537 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.903613e-01 | 0.537 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 2.903613e-01 | 0.537 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.903613e-01 | 0.537 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.903613e-01 | 0.537 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.904788e-01 | 0.537 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.981776e-01 | 0.526 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.981776e-01 | 0.526 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.981776e-01 | 0.526 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.981776e-01 | 0.526 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.030609e-01 | 0.518 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 3.034236e-01 | 0.518 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.054801e-01 | 0.515 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.059082e-01 | 0.514 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.059082e-01 | 0.514 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.059082e-01 | 0.514 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.059082e-01 | 0.514 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.059082e-01 | 0.514 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.071179e-01 | 0.513 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.084852e-01 | 0.511 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.135541e-01 | 0.504 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.135541e-01 | 0.504 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.135541e-01 | 0.504 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.135541e-01 | 0.504 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.135541e-01 | 0.504 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.152182e-01 | 0.501 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 3.168686e-01 | 0.499 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.192607e-01 | 0.496 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.211163e-01 | 0.493 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.211163e-01 | 0.493 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.211163e-01 | 0.493 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.211163e-01 | 0.493 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.211163e-01 | 0.493 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.232977e-01 | 0.490 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.273286e-01 | 0.485 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.285957e-01 | 0.483 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.285957e-01 | 0.483 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.285957e-01 | 0.483 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.285957e-01 | 0.483 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.285957e-01 | 0.483 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.285957e-01 | 0.483 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.353712e-01 | 0.474 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.359931e-01 | 0.474 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.359931e-01 | 0.474 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.359931e-01 | 0.474 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.359931e-01 | 0.474 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.359931e-01 | 0.474 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.393822e-01 | 0.469 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.433094e-01 | 0.464 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.433094e-01 | 0.464 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 3.433094e-01 | 0.464 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.473818e-01 | 0.459 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.505456e-01 | 0.455 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.505456e-01 | 0.455 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.505456e-01 | 0.455 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.553496e-01 | 0.449 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.577025e-01 | 0.446 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.577025e-01 | 0.446 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 3.647810e-01 | 0.438 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.647810e-01 | 0.438 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.647810e-01 | 0.438 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.647810e-01 | 0.438 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.647810e-01 | 0.438 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.717819e-01 | 0.430 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.717819e-01 | 0.430 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.717819e-01 | 0.430 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.717819e-01 | 0.430 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.717819e-01 | 0.430 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 3.717819e-01 | 0.430 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 3.787060e-01 | 0.422 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.787060e-01 | 0.422 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.790380e-01 | 0.421 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.855543e-01 | 0.414 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.855543e-01 | 0.414 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.855543e-01 | 0.414 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.855543e-01 | 0.414 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.923275e-01 | 0.406 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.923275e-01 | 0.406 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.923275e-01 | 0.406 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.990264e-01 | 0.399 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.990264e-01 | 0.399 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.990264e-01 | 0.399 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.990264e-01 | 0.399 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.990264e-01 | 0.399 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.990264e-01 | 0.399 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.990264e-01 | 0.399 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.990264e-01 | 0.399 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.056519e-01 | 0.392 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.056519e-01 | 0.392 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.056519e-01 | 0.392 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.056519e-01 | 0.392 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.056519e-01 | 0.392 | 1 | 1 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.056519e-01 | 0.392 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.056519e-01 | 0.392 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.100424e-01 | 0.387 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 4.109057e-01 | 0.386 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.122048e-01 | 0.385 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.122048e-01 | 0.385 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.176775e-01 | 0.379 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 4.176775e-01 | 0.379 | 1 | 1 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.186858e-01 | 0.378 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.186858e-01 | 0.378 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.186858e-01 | 0.378 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.186858e-01 | 0.378 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.186858e-01 | 0.378 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.252629e-01 | 0.371 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.314355e-01 | 0.365 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.327970e-01 | 0.364 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.377056e-01 | 0.359 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.377056e-01 | 0.359 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.377056e-01 | 0.359 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.377056e-01 | 0.359 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.402787e-01 | 0.356 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.439070e-01 | 0.353 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 4.439070e-01 | 0.353 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.439070e-01 | 0.353 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.439070e-01 | 0.353 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.439070e-01 | 0.353 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.439070e-01 | 0.353 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.439070e-01 | 0.353 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.439070e-01 | 0.353 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.439070e-01 | 0.353 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.451363e-01 | 0.352 | 1 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.500404e-01 | 0.347 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.500404e-01 | 0.347 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.500404e-01 | 0.347 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.500404e-01 | 0.347 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.500404e-01 | 0.347 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.561065e-01 | 0.341 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.621061e-01 | 0.335 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.621061e-01 | 0.335 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.621061e-01 | 0.335 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.696543e-01 | 0.328 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.739085e-01 | 0.324 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.739085e-01 | 0.324 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.797128e-01 | 0.319 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.797128e-01 | 0.319 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.797128e-01 | 0.319 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.854534e-01 | 0.314 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.854534e-01 | 0.314 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.854534e-01 | 0.314 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.854534e-01 | 0.314 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.875446e-01 | 0.312 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.911310e-01 | 0.309 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.911310e-01 | 0.309 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.050568e-01 | 0.297 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.077927e-01 | 0.294 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.185980e-01 | 0.285 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 5.239119e-01 | 0.281 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.239119e-01 | 0.281 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.291674e-01 | 0.276 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.291674e-01 | 0.276 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.305885e-01 | 0.275 | 1 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.343653e-01 | 0.272 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.343653e-01 | 0.272 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.343653e-01 | 0.272 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.395060e-01 | 0.268 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.395060e-01 | 0.268 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.395060e-01 | 0.268 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.445904e-01 | 0.264 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.445904e-01 | 0.264 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.445904e-01 | 0.264 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.487446e-01 | 0.261 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.487446e-01 | 0.261 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.496189e-01 | 0.260 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.496189e-01 | 0.260 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.496189e-01 | 0.260 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.545922e-01 | 0.256 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.552233e-01 | 0.256 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.643755e-01 | 0.248 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.691868e-01 | 0.245 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.786513e-01 | 0.238 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.786513e-01 | 0.238 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.833057e-01 | 0.234 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.833057e-01 | 0.234 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.833057e-01 | 0.234 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.866281e-01 | 0.232 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.879091e-01 | 0.231 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.924618e-01 | 0.227 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.924618e-01 | 0.227 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.969645e-01 | 0.224 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 6.072955e-01 | 0.217 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.144860e-01 | 0.211 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.144860e-01 | 0.211 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.144860e-01 | 0.211 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 6.187467e-01 | 0.208 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 6.187467e-01 | 0.208 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.187467e-01 | 0.208 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.188867e-01 | 0.208 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.229606e-01 | 0.206 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.229606e-01 | 0.206 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.229606e-01 | 0.206 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.271282e-01 | 0.203 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.312499e-01 | 0.200 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.353264e-01 | 0.197 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.393580e-01 | 0.194 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.433453e-01 | 0.192 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.472888e-01 | 0.189 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.472888e-01 | 0.189 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 6.511889e-01 | 0.186 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.550461e-01 | 0.184 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.626338e-01 | 0.179 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.663651e-01 | 0.176 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.773147e-01 | 0.169 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.773147e-01 | 0.169 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.808846e-01 | 0.167 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.879069e-01 | 0.162 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.947756e-01 | 0.158 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.981533e-01 | 0.156 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.014939e-01 | 0.154 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.047977e-01 | 0.152 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.080652e-01 | 0.150 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.112967e-01 | 0.148 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.112967e-01 | 0.148 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.207792e-01 | 0.142 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.207792e-01 | 0.142 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.269282e-01 | 0.139 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.299520e-01 | 0.137 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.359001e-01 | 0.133 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.359001e-01 | 0.133 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.474083e-01 | 0.126 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.474083e-01 | 0.126 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.610946e-01 | 0.119 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 7.630857e-01 | 0.117 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 7.638080e-01 | 0.117 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.910072e-01 | 0.102 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.346665e-01 | 0.078 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.401137e-01 | 0.076 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.436456e-01 | 0.074 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.487986e-01 | 0.071 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.521397e-01 | 0.069 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.601748e-01 | 0.065 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.648034e-01 | 0.063 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.777312e-01 | 0.057 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.790912e-01 | 0.056 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.790912e-01 | 0.056 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.817662e-01 | 0.055 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.817662e-01 | 0.055 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.881992e-01 | 0.051 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.954608e-01 | 0.048 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.011525e-01 | 0.045 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.054831e-01 | 0.043 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.271471e-01 | 0.033 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.293805e-01 | 0.032 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.317182e-01 | 0.031 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.442132e-01 | 0.025 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.490096e-01 | 0.023 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.598460e-01 | 0.018 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.640241e-01 | 0.016 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.656090e-01 | 0.015 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.785863e-01 | 0.009 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.840750e-01 | 0.007 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.891406e-01 | 0.005 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.917294e-01 | 0.004 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.917294e-01 | 0.004 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.935710e-01 | 0.003 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.961951e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.970514e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.996438e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999302e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999701e-01 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
